GlassScriptPhysician profile
Marie Jhin
NPI 1104878321
$5,236.86
in general payments reported to CMS, 2019-2025
21 companies · $406 in 2025
The $406 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $657 · 2021: $1,333 · 2022: $694 · 2023: $638 · 2024: $439 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $101.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,440.76 | 2019-2025 | |
| Merz North America, INC. | $1,340.39 | 2019-2025 | |
| Allergan, INC. | $955.87 | 2019-2022 | |
| Galderma Laboratories, L.P. | $780.54 | 2019-2025 | Dysport |
| Regeneron Healthcare Solutions, INC. | $178.71 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $90.55 | 2020-2021 | |
| Dermira, INC. | $61.55 | 2020-2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $49.67 | 2021-2025 | Clear+Brilliant |
| Aclaris Therapeutics, INC. | $46.34 | 2019 | |
| Pfizer INC. | $45.93 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $44.99 | 2019-2021 | |
| Revance Therapeutics, INC. | $41.95 | 2024 | Daxxify |
| Ucb, INC. | $24.51 | 2023 | Bimzelx |
| Almirall LLC | $24.10 | 2019 | |
| Amgen INC. | $24.07 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $22.29 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.30 | 2019 | |
| Leo Pharma INC. | $14.21 | 2019 | |
| Sun Pharmaceutical Industries INC. | $12.84 | 2021 | |
| Incyte Corporation | $11.92 | 2021 | |
| Organon LLC | $9.37 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Jhin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.